Brookstone Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-33,506
| Closed | -$666K | – | 998 |
|
|
2024
Q3 | $666K | Hold |
33,506
| – | – | 0.01% | 618 |
|
|
2024
Q2 | $566K | Hold |
33,506
| – | – | 0.01% | 626 |
|
|
2024
Q1 | $534K | Hold |
33,506
| – | – | 0.01% | 613 |
|
|
2023
Q4 | $563K | Buy |
33,506
+38
| +0.1% | +$639 | 0.01% | 573 |
|
|
2023
Q3 | $433K | Sell |
33,468
-3,439
| -9% | -$44.5K | 0.01% | 605 |
|
|
2023
Q2 | $455K | Buy |
36,907
+3,439
| +10% | +$42.4K | 0.01% | 602 |
|
|
2023
Q1 | $605K | Sell |
33,468
-50
| -0.1% | -$904 | 0.01% | 551 |
|
|
2022
Q4 | $657K | Buy |
33,518
+49
| +0.1% | +$960 | 0.01% | 529 |
|
|
2022
Q3 | $415K | Buy |
+33,469
| New | +$415K | 0.01% | 595 |
|
|
2021
Q3 | – | Sell |
-16,472
| Closed | -$91K | – | 736 |
|
|
2021
Q2 | $91K | Buy |
16,472
+1,082
| +7% | +$5.98K | ﹤0.01% | 693 |
|
|
2021
Q1 | $71K | Buy |
+15,390
| New | +$71K | ﹤0.01% | 492 |
|